Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.
Saved in:
| Title: | Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer. |
|---|---|
| Authors: | Kudo-Saito C; Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan. ckudo@ncc.go.jp., Imazeki H; Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Nagashima K; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan., Shoji H; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Tsugaru K; Division of Gastroenterology and Hepatology, Keio University Hospital, Tokyo, Japan., Takahashi N; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan., Kawakami T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Amanuma Y; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan., Wakatsuki T; Department of Gastrointestinal Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan., Okano N; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan., Narita Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Yamamoto Y; Department of Gastroenterology, University of Tsukuba Hospital, Tsukuba, Japan., Kizawa R; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Boku N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology and General Medicine, Institute of Medical Science, IMS Hospital, University of Tokyo, Tokyo, Japan. |
| Source: | Discover oncology [Discov Oncol] 2025 Oct 22; Vol. 16 (1), pp. 1951. Date of Electronic Publication: 2025 Oct 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41123746 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Peripheral SNCA<superscript>+</superscript> cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kudo-Saito+C%22">Kudo-Saito C</searchLink>; Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan. ckudo@ncc.go.jp.<br /><searchLink fieldCode="AU" term="%22Imazeki+H%22">Imazeki H</searchLink>; Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nagashima+K%22">Nagashima K</searchLink>; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shoji+H%22">Shoji H</searchLink>; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsugaru+K%22">Tsugaru K</searchLink>; Division of Gastroenterology and Hepatology, Keio University Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+N%22">Takahashi N</searchLink>; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Kawakami+T%22">Kawakami T</searchLink>; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Amanuma+Y%22">Amanuma Y</searchLink>; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Wakatsuki+T%22">Wakatsuki T</searchLink>; Department of Gastrointestinal Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Okano+N%22">Okano N</searchLink>; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Narita+Y%22">Narita Y</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+Y%22">Yamamoto Y</searchLink>; Department of Gastroenterology, University of Tsukuba Hospital, Tsukuba, Japan.<br /><searchLink fieldCode="AU" term="%22Kizawa+R%22">Kizawa R</searchLink>; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Muro+K%22">Muro K</searchLink>; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Boku+N%22">Boku N</searchLink>; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology and General Medicine, Institute of Medical Science, IMS Hospital, University of Tokyo, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101775142%22">Discover oncology</searchLink> [Discov Oncol] 2025 Oct 22; Vol. 16 (1), pp. 1951. <i>Date of Electronic Publication: </i>2025 Oct 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101775142 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-6011 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227306011%22">27306011 </searchLink><i>NLM ISO Abbreviation: </i>Discov Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41123746 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12672-025-03817-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1951 Titles: – TitleFull: Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kudo-Saito C – PersonEntity: Name: NameFull: Imazeki H – PersonEntity: Name: NameFull: Nagashima K – PersonEntity: Name: NameFull: Shoji H – PersonEntity: Name: NameFull: Tsugaru K – PersonEntity: Name: NameFull: Takahashi N – PersonEntity: Name: NameFull: Kawakami T – PersonEntity: Name: NameFull: Amanuma Y – PersonEntity: Name: NameFull: Wakatsuki T – PersonEntity: Name: NameFull: Okano N – PersonEntity: Name: NameFull: Narita Y – PersonEntity: Name: NameFull: Yamamoto Y – PersonEntity: Name: NameFull: Kizawa R – PersonEntity: Name: NameFull: Muro K – PersonEntity: Name: NameFull: Boku N IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 10 Text: 2025 Oct 22 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2730-6011 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Discover oncology Type: main |
| ResultId | 1 |